Literature DB >> 22008331

Increasing national burden of hospitalizations for skin and soft tissue infections in children.

Timothy B Lautz1, Mehul V Raval, Katherine A Barsness.   

Abstract

BACKGROUND: The number of children requiring treatment of skin and soft tissue infections (SSTIs) has increased since the emergence of methicillin-resistant Staphylococcus aureus.
METHODS: The 2000, 2003, and 2006 Kids' Inpatient Databases were queried for patients with a primary diagnosis of SSTI. Weighted data were analyzed to estimate temporal changes in incidence, incision and drainage (I&D) rate, and economic burden. Factors associated with I&D were analyzed by multivariable logistic regression.
RESULTS: Pediatric SSTI admissions increased (1) in number, (2) as a fraction of all hospital admissions, and (3) in incidence per 100,000 children from the years 2000 (17,525 ± 838; 0.65%; 23.2) to 2003 (27,463 ± 1652; 0.99%; 36.2) and 2006 (48,228 ± 2223; 1.77%; 62.7). Children younger than 3 years accounted for 49.6% of SSTI admissions in 2006, up from 32.5% in 2000. Utilization of I&D increased during the study period from 26.0% to 43.8%. Factors most associated with requiring I&D were age less than 3 years and calendar year 2006 (both P < .001). Hospital costs per patient increased over time and were higher in the group of patients who required I&D ($4296 ± $84 vs $3521 ± $81; P < .001; year 2006). Aggregate national costs reached $184.0 ± $9.4 million in 2006.
CONCLUSION: The recent spike in pediatric SSTIs has disproportionately affected children younger than 3 years, and an increasing fraction of these children require I&D. The national economic burden is substantial.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22008331     DOI: 10.1016/j.jpedsurg.2011.05.008

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  9 in total

1.  Trends in resource utilization for hospitalized children with skin and soft tissue infections.

Authors:  Michelle A Lopez; Andrea T Cruz; Marc A Kowalkowski; Jean L Raphael
Journal:  Pediatrics       Date:  2013-02-25       Impact factor: 7.124

2.  Population-based study of the increased incidence of skin and soft tissue infections and associated antimicrobial use.

Authors:  Fawziah Marra; David M Patrick; Mei Chong; Rachel McKay; Linda Hoang; William R Bowie
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

3.  Impact of Decolonization Protocols and Recurrence in Pediatric MRSA Skin and Soft-Tissue Infections.

Authors:  Steven T Papastefan; Christie Buonpane; Guillermo Ares; Beshoy Benyamen; Irene Helenowski; Catherine J Hunter
Journal:  J Surg Res       Date:  2019-05-06       Impact factor: 2.192

4.  Update on Epidemiology and Treatment of MRSA Infections in Children.

Authors:  Michael Z David; Robert S Daum
Journal:  Curr Pediatr Rep       Date:  2013-09-01

5.  Antibiotic prescribing practices in a multicenter cohort of patients hospitalized for acute bacterial skin and skin structure infection.

Authors:  Timothy C Jenkins; Bryan C Knepper; S Jason Moore; Sean T O'Leary; Carla C Saveli; Sean W Pawlowski; Daniel M Perlman; Bruce D McCollister; William J Burman
Journal:  Infect Control Hosp Epidemiol       Date:  2014-08-20       Impact factor: 3.254

6.  Clinical characteristics and antibiotic utilization in pediatric patients hospitalized with acute bacterial skin and skin structure infection.

Authors:  S Jason Moore; Sean T O'Leary; Brooke Caldwell; Bryan C Knepper; Sean W Pawlowski; William J Burman; Timothy C Jenkins
Journal:  Pediatr Infect Dis J       Date:  2014-08       Impact factor: 2.129

7.  Factors associated with high resource utilization in pediatric skin and soft tissue infection hospitalizations.

Authors:  Michelle A Lopez; Andrea T Cruz; Marc A Kowalkowski; Jean L Raphael
Journal:  Hosp Pediatr       Date:  2013-10

8.  The efficacy and safety of ceftaroline in the treatment of acute bacterial infection in pediatric patients - a systemic review and meta-analysis of randomized controlled trials.

Authors:  Chih-Wei Chen; Shen-Peng Chang; Hui-Ting Huang; Hung-Jen Tang; Chih-Cheng Lai
Journal:  Infect Drug Resist       Date:  2019-05-15       Impact factor: 4.003

Review 9.  Use of nitric oxide nanoparticulate platform for the treatment of skin and soft tissue infections.

Authors:  Allison J Kutner; Adam J Friedman
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-05-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.